Lynn Kysh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lynn Kysh has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Zoë Baker
Arizona State University USA
5 shared publications - Emily A. Brennan
Medical University of South Carolina USA
4 shared publications - James Dickhoner
Innovation Studio, Children’s Hospital Los Angeles, Los Angeles, California, USA
4 shared publications - Rachel J. Hinrichs
Indiana University Indianapolis USA
4 shared publications - Roxanne Bogucka
University of Texas Austin (Emeritus) USA
4 shared publications - Christine Willis
Children's Healthcare of Atlanta USA
3 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by CABI Publishing
Infant Population Simple Search (0-23 months) (PubMed).
This is a simple, yet sensitive validated search hedge for the infant population (0-23 months) for use in PubMed. Based on the study published in JMLA, this search hedge has 83.5% sensitivity and 89.7% specificity. See the paper for more detail.
- 29 August 2026
- Published by CABI Publishing
Open AccessInfant Population Simple Search (0-23 months) (PubMed).
This is a simple, yet sensitive validated search hedge for the infant population (0-23 months) for use in PubMed. Based on the study published in JMLA, this search hedge has 83.5% sensitivity and 89.7% specificity. See the paper for more detail.
- Open Access
- 29 August 2026
- Published by CABI Publishing
Infant Population Comprehensive Search (0-23 months) (MEDLINE).
This is a sensitive, comprehensive, validated search hedge for the infant population (0-23 months) for use in MEDLINE Ovid. Based on the study published in JMLA, this search hedge has 83.6% sensitivity and 88.1% specificity. The All Fields tags can be switched out to text word or title/abstract tags with little change to the sensitivity and specificity. See the paper for more detail.
- 29 August 2026
- Published by CABI Publishing
Open AccessInfant Population Comprehensive Search (0-23 months) (MEDLINE).
This is a sensitive, comprehensive, validated search hedge for the infant population (0-23 months) for use in MEDLINE Ovid. Based on the study published in JMLA, this search hedge has 83.6% sensitivity and 88.1% specificity. The All Fields tags can be switched out to text word or title/abstract tags with little change to the sensitivity and specificity. See the paper for more detail.
- Open Access
- 29 August 2026
- Published by CABI Publishing
Infant Population Comprehensive Search (0-23 months) (PubMed).
This is a sensitive, comprehensive, validated search hedge for the infant population (0-23 months) for use in PubMed. Based on the study published in JMLA, this search hedge has 83.8% sensitivity and 88.2% specificity. The All Fields tags can be switched out to text word or title/abstract tags with little change to the sensitivity and specificity. See the paper for more detail.
- 29 August 2026
- Published by CABI Publishing
Open AccessInfant Population Comprehensive Search (0-23 months) (PubMed).
This is a sensitive, comprehensive, validated search hedge for the infant population (0-23 months) for use in PubMed. Based on the study published in JMLA, this search hedge has 83.8% sensitivity and 88.2% specificity. The All Fields tags can be switched out to text word or title/abstract tags with little change to the sensitivity and specificity. See the paper for more detail.
- Open Access
- 23 October 2025
- Published by University Library System, University of Pittsburgh in Journal of the Medical Library Association
- Vol. 113 (4) , 281-289
Developing and validating PubMed infant hedges for PubMed and Ovid MEDLINE: a Medical Library Association pediatrics librarians caucus initiative
Background: To support evidence synthesis and clinical searching, a team of librarians developed and validated infant age (birth to 23 months) search hedges for PubMed (National Library of Medicine) and Medline (OVID). Methods: We developed four sensitive hedges by selecting terms that refer to infants. Three of the hedges had identical MeSH terms and keywords but used different field tags, and the fourth was a simple keyword hedge. We compared our hedges to the built-in MeSH-based infant filter. We used relative recall calculations to validate each hedge’s performance against a gold standard reference set. Results: In PubMed the similarly structured hedges performed in a range of 83.2%-83.8% sensitivity and 88.2%-89.7% specificity. The simple keyword hedge performed with an 83.5% sensitivity and 89.7% specificity. The filter generated a 70.1% sensitivity and 96.2% specificity. Similarly, in Ovid Medline, the set of similar hedges performed in a range of 82.9%-83.6% sensitivity and 88.1%-89.4% specificity. The simple keyword hedge performed with an 82.9% sensitivity and 90.8% specificity. The filter generated a 69.6% sensitivity and 96.2% specificity. Discussion: The variation in field tags did not provide a significant difference in the areas of sensitivity and specificity. The filter performed as expected with higher specificity rather than sensitivity. The simple keyword hedge performed better than anticipated with comparable sensitivity and specificity of the more complex hedges. When searching for infant population articles, the simple keyword search and filter work well for quick, clinical searching. For evidence synthesis, we recommend using one of the more sensitive infant hedges.
- 23 October 2025
- Published by University Library System, University of Pittsburgh in Journal of the Medical Library Association
- Vol. 113 (4) , 281-289
Open AccessDeveloping and validating PubMed infant hedges for PubMed and Ovid MEDLINE: a Medical Library Association pediatrics librarians caucus initiative
Background: To support evidence synthesis and clinical searching, a team of librarians developed and validated infant age (birth to 23 months) search hedges for PubMed (National Library of Medicine) and Medline (OVID). Methods: We developed four sensitive hedges by selecting terms that refer to infants. Three of the hedges had identical MeSH terms and keywords but used different field tags, and the fourth was a simple keyword hedge. We compared our hedges to the built-in MeSH-based infant filter. We used relative recall calculations to validate each hedge’s performance against a gold standard reference set. Results: In PubMed the similarly structured hedges performed in a range of 83.2%-83.8% sensitivity and 88.2%-89.7% specificity. The simple keyword hedge performed with an 83.5% sensitivity and 89.7% specificity. The filter generated a 70.1% sensitivity and 96.2% specificity. Similarly, in Ovid Medline, the set of similar hedges performed in a range of 82.9%-83.6% sensitivity and 88.1%-89.4% specificity. The simple keyword hedge performed with an 82.9% sensitivity and 90.8% specificity. The filter generated a 69.6% sensitivity and 96.2% specificity. Discussion: The variation in field tags did not provide a significant difference in the areas of sensitivity and specificity. The filter performed as expected with higher specificity rather than sensitivity. The simple keyword hedge performed better than anticipated with comparable sensitivity and specificity of the more complex hedges. When searching for infant population articles, the simple keyword search and filter work well for quick, clinical searching. For evidence synthesis, we recommend using one of the more sensitive infant hedges.
- Open Access
- 26 June 2025
- Published by IOS Press
- Vol. 328, 474-475
Health Informatics Training Programs in LMICs: A Scoping Review
To better support health informatics training and mentorship programs in LMICs, evidence of past trainings in imperative. We set out to conduct a scoping review to explore and chart the evidence of health informatics education in LMICs to identify trends, successes, and pitfalls. Over 12,000 studies were screened and full text reviews conducted for 774 studies. With trending positive results, we acknowledge that is important to understand the landscape of health informatics and conduct needs assessment prior to establishing such a training program in an LMIC.
- 26 June 2025
- Published by IOS Press
- Vol. 328, 474-475
Open AccessHealth Informatics Training Programs in LMICs: A Scoping Review
To better support health informatics training and mentorship programs in LMICs, evidence of past trainings in imperative. We set out to conduct a scoping review to explore and chart the evidence of health informatics education in LMICs to identify trends, successes, and pitfalls. Over 12,000 studies were screened and full text reviews conducted for 774 studies. With trending positive results, we acknowledge that is important to understand the landscape of health informatics and conduct needs assessment prior to establishing such a training program in an LMIC.
- 21 September 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (6) , 1044-1056
Mental health, psychosocial functioning, and health-related quality of life of children and adolescents with bladder exstrophy, cloacal exstrophy, and epispadias: A scoping review
- 21 September 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (6) , 1044-1056
Mental health, psychosocial functioning, and health-related quality of life of children and adolescents with bladder exstrophy, cloacal exstrophy, and epispadias: A scoping review
- Open Access
Barriers to and facilitators of paediatric medical device innovation: a scoping review protocol
Introduction The development of paediatric medical devices continues to lag adult medical devices and contributes to issues of inequity, safety, quality and patient outcomes. New legislation and funding mechanisms have been introduced over the past two decades, but the gap remains. Clinical trials have been identified as a pain point, but components of effective clinical research infrastructure are poorly understood. As part of a multimodal research strategy, the Pediatric Device Consortia (PDC) will conduct a scoping review to better understand infrastructural barriers to and facilitators of paediatric medical device clinical research identified in the health sciences literature. Methods and analysis The following databases will be included for this review: Medline, Embase, Cochrane CENTRAL, Web of Science and IEEE Xplore. Additional grey literature will be sought out through Google Scholar and reviewing the citations of included studies. Included studies will discuss medical devices according to the U.S. Food and Drug Administration classification, focus on the paediatric population (ages 0–21 years) and involve human premarket or postmarket research. All study types that were published in 2007–present in English, Spanish, French or Italian will be included. Using Covidence web-based software, two independent reviewers will screen the resulting titles, abstracts and the full text of potential studies. Conflicts will be resolved by the primary investigator during both phases. REDCap will be used for quantitative and qualitative data charting, generating data tables and narrative synthesis. Ethics and dissemination This research did not require research ethics board consideration as it does not involve human participants and all data will be collected from published literature. We will share our findings through peer-reviewed manuscripts, clinical and research conference presentations and professional networks available to the PDC. Study registration Open Science Framework (https://osf.io/k72bn).
Open AccessBarriers to and facilitators of paediatric medical device innovation: a scoping review protocol
Introduction The development of paediatric medical devices continues to lag adult medical devices and contributes to issues of inequity, safety, quality and patient outcomes. New legislation and funding mechanisms have been introduced over the past two decades, but the gap remains. Clinical trials have been identified as a pain point, but components of effective clinical research infrastructure are poorly understood. As part of a multimodal research strategy, the Pediatric Device Consortia (PDC) will conduct a scoping review to better understand infrastructural barriers to and facilitators of paediatric medical device clinical research identified in the health sciences literature. Methods and analysis The following databases will be included for this review: Medline, Embase, Cochrane CENTRAL, Web of Science and IEEE Xplore. Additional grey literature will be sought out through Google Scholar and reviewing the citations of included studies. Included studies will discuss medical devices according to the U.S. Food and Drug Administration classification, focus on the paediatric population (ages 0–21 years) and involve human premarket or postmarket research. All study types that were published in 2007–present in English, Spanish, French or Italian will be included. Using Covidence web-based software, two independent reviewers will screen the resulting titles, abstracts and the full text of potential studies. Conflicts will be resolved by the primary investigator during both phases. REDCap will be used for quantitative and qualitative data charting, generating data tables and narrative synthesis. Ethics and dissemination This research did not require research ethics board consideration as it does not involve human participants and all data will be collected from published literature. We will share our findings through peer-reviewed manuscripts, clinical and research conference presentations and professional networks available to the PDC. Study registration Open Science Framework (https://osf.io/k72bn).
- Open Access
- 31 March 2024
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 22 (1) , 78-94
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
Purpose: Diabetes mellitus, a frequent comorbid condition in cancer patients, has been shown to increase risk of all-site cancer mortality. This relationship has not been systematically studied in bladder cancer patients. This systematic review and meta-analysis aimed to identify, evaluate, and synthesize available evidence on the relationship between history of diabetes and outcomes in bladder cancer patients.Materials and Methods: Systematic searches interrogated OVID MEDLINE, Embase, Web of Science, Google Scholar, and Cochrane Library to identify scholarly reports relating diabetes to all-cause mortality, bladder cancer-specific mortality, recurrence, and progression in bladder cancer patients. After critical review, meta-analysis was used to quantitively synthesize qualifying data and assess potential influence of publication bias, clinical heterogeneity, and residual confounding.Results: We synthesized data on over 226,472 patients treated with curative intent uniquely represented in 28 studies that met quality metrics. Having diabetes was positively associated with each outcome. Hazard ratio estimates were indistinguishable for mortality from any cause, 1.22 (95% confidence interval [CI], 1.12–1.33) and bladder cancer-specific mortality, 1.28 (95% CI 1.17–1.41) and notably stronger in patients with muscle-invasive and high-risk non–muscle-invasive bladder cancer, 1.32 (95% CI, 1.15–1.50) and 1.48 (95% CI, 1.06–2.06). Neither publication bias, systematic error, nor confounding by factors such as smoking or obesity is likely to explain the observed associations.Conclusions: Bladder cancer patients with diabetes experience elevated mortality that is not explained by diabetes-related comorbidities or complications. Future research should explore type, severity, and duration of diabetes in relation to unfavorable bladder cancer outcomes.
- 31 March 2024
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 22 (1) , 78-94
Open AccessPoorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
Purpose: Diabetes mellitus, a frequent comorbid condition in cancer patients, has been shown to increase risk of all-site cancer mortality. This relationship has not been systematically studied in bladder cancer patients. This systematic review and meta-analysis aimed to identify, evaluate, and synthesize available evidence on the relationship between history of diabetes and outcomes in bladder cancer patients.Materials and Methods: Systematic searches interrogated OVID MEDLINE, Embase, Web of Science, Google Scholar, and Cochrane Library to identify scholarly reports relating diabetes to all-cause mortality, bladder cancer-specific mortality, recurrence, and progression in bladder cancer patients. After critical review, meta-analysis was used to quantitively synthesize qualifying data and assess potential influence of publication bias, clinical heterogeneity, and residual confounding.Results: We synthesized data on over 226,472 patients treated with curative intent uniquely represented in 28 studies that met quality metrics. Having diabetes was positively associated with each outcome. Hazard ratio estimates were indistinguishable for mortality from any cause, 1.22 (95% confidence interval [CI], 1.12–1.33) and bladder cancer-specific mortality, 1.28 (95% CI 1.17–1.41) and notably stronger in patients with muscle-invasive and high-risk non–muscle-invasive bladder cancer, 1.32 (95% CI, 1.15–1.50) and 1.48 (95% CI, 1.06–2.06). Neither publication bias, systematic error, nor confounding by factors such as smoking or obesity is likely to explain the observed associations.Conclusions: Bladder cancer patients with diabetes experience elevated mortality that is not explained by diabetes-related comorbidities or complications. Future research should explore type, severity, and duration of diabetes in relation to unfavorable bladder cancer outcomes.
- Open Access
- 11 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Multiplatform approach to asynchronous continuing medical education in low- and middle-income countries (Preprint)
BACKGROUND Good health and quality education are important preconditions to sustainable development and capacity building in global health partnerships. Research shows that there is a need for exploring and documenting the process of organizing online medical education programs in low- and middle-income countries (LMICs) and developing new conceptual models for enhancing learning and engagement for healthcare professionals. OBJECTIVE The goal of this qualitative study was to explore multidisciplinary team experiences with developing multiplatform continuing medical education training programs for healthcare professionals in low- and middle-income countries (LMICs), specifically focusing on the Republic of Armenia, an LMIC located in the southern Caucasus region METHODS A qualitative study with semi-structured focus group interviews was conducted with 10 multidisciplinary experts involved in the development of the program. The qualitative data was analyzed using the NVivo 12 qualitative data analysis software. The thematic analysis involved two cycles of coding to identify the emergent themes and related sub-themes. RESULTS The analysis of the qualitative data from the focus groups resulted in four major themes and related sub-themes. The major themes included Lessons Learned, Challenges, Recommendations, and Future Directions. CONCLUSIONS This work can serve as a model for healthcare education program managers that focus on the development of asynchronous virtual medical training for LMICs thus contributing to sustainable development and capacity building in global health partnerships. CLINICALTRIAL N/A
- 11 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMultiplatform approach to asynchronous continuing medical education in low- and middle-income countries (Preprint)
BACKGROUND Good health and quality education are important preconditions to sustainable development and capacity building in global health partnerships. Research shows that there is a need for exploring and documenting the process of organizing online medical education programs in low- and middle-income countries (LMICs) and developing new conceptual models for enhancing learning and engagement for healthcare professionals. OBJECTIVE The goal of this qualitative study was to explore multidisciplinary team experiences with developing multiplatform continuing medical education training programs for healthcare professionals in low- and middle-income countries (LMICs), specifically focusing on the Republic of Armenia, an LMIC located in the southern Caucasus region METHODS A qualitative study with semi-structured focus group interviews was conducted with 10 multidisciplinary experts involved in the development of the program. The qualitative data was analyzed using the NVivo 12 qualitative data analysis software. The thematic analysis involved two cycles of coding to identify the emergent themes and related sub-themes. RESULTS The analysis of the qualitative data from the focus groups resulted in four major themes and related sub-themes. The major themes included Lessons Learned, Challenges, Recommendations, and Future Directions. CONCLUSIONS This work can serve as a model for healthcare education program managers that focus on the development of asynchronous virtual medical training for LMICs thus contributing to sustainable development and capacity building in global health partnerships. CLINICALTRIAL N/A
- Open Access
- 11 December 2023
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 10 (1) , e001182
Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol
Introduction Inflammatory bowel diseases (IBD) are immune-mediated conditions that are increasing in incidence and prevalence worldwide. Their assessment and monitoring are becoming increasingly important, though complex. The best disease control is achieved through tight monitoring of objective inflammatory parameters (such as serum and stool inflammatory markers), cross-sectional imaging and endoscopic assessment. Considering the complexity of the information obtained throughout a patient’s journey, artificial intelligence (AI) provides an ideal adjunct to existing tools to help diagnose, monitor and predict the course of disease of patients with IBD. Therefore, we propose a scoping review assessing AI’s role in diagnosis, monitoring and prognostication tools in patients with IBD. We aim to detect gaps in the literature and address them in future research endeavours. Methods and analysis We will search electronic databases, including Medline, Embase, Cochrane CENTRAL, CINAHL Complete, Web of Science and IEEE Xplore. Two reviewers will independently screen the abstracts and titles first and then perform the full-text review. A third reviewer will resolve any conflict. We will include both observational studies and clinical trials. Study characteristics will be extracted using a data extraction form. The extracted data will be summarised in a tabular format, following the imaging modality theme and the study outcome assessed. The results will have an accompanying narrative review. Ethics and dissemination Considering the nature of the project, ethical review by an institutional review board is not required. The data will be presented at academic conferences, and the final product will be published in a peer-reviewed journal.
- 11 December 2023
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 10 (1) , e001182
Open AccessRole of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol
Introduction Inflammatory bowel diseases (IBD) are immune-mediated conditions that are increasing in incidence and prevalence worldwide. Their assessment and monitoring are becoming increasingly important, though complex. The best disease control is achieved through tight monitoring of objective inflammatory parameters (such as serum and stool inflammatory markers), cross-sectional imaging and endoscopic assessment. Considering the complexity of the information obtained throughout a patient’s journey, artificial intelligence (AI) provides an ideal adjunct to existing tools to help diagnose, monitor and predict the course of disease of patients with IBD. Therefore, we propose a scoping review assessing AI’s role in diagnosis, monitoring and prognostication tools in patients with IBD. We aim to detect gaps in the literature and address them in future research endeavours. Methods and analysis We will search electronic databases, including Medline, Embase, Cochrane CENTRAL, CINAHL Complete, Web of Science and IEEE Xplore. Two reviewers will independently screen the abstracts and titles first and then perform the full-text review. A third reviewer will resolve any conflict. We will include both observational studies and clinical trials. Study characteristics will be extracted using a data extraction form. The extracted data will be summarised in a tabular format, following the imaging modality theme and the study outcome assessed. The results will have an accompanying narrative review. Ethics and dissemination Considering the nature of the project, ethical review by an institutional review board is not required. The data will be presented at academic conferences, and the final product will be published in a peer-reviewed journal.